Cannabis Bioscience Pink Sheet Forecast - Naive Prediction
| CBIH Stock | 0.0005 0.0002 28.57% |
Momentum 0
Sell Peaked
Oversold | Overbought |
Using Cannabis Bioscience hype-based prediction, you can estimate the value of Cannabis Bioscience International from the perspective of Cannabis Bioscience response to recently generated media hype and the effects of current headlines on its competitors.
The Naive Prediction forecasted value of Cannabis Bioscience International on the next trading day is expected to be 0.0005 with a mean absolute deviation of 0.000051 and the sum of the absolute errors of 0. Cannabis Bioscience after-hype prediction price | USD 3.18E-4 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Cannabis |
Cannabis Bioscience Additional Predictive Modules
Most predictive techniques to examine Cannabis price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Cannabis using various technical indicators. When you analyze Cannabis charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cannabis Bioscience Naive Prediction Price Forecast For the 24th of January
Given 90 days horizon, the Naive Prediction forecasted value of Cannabis Bioscience International on the next trading day is expected to be 0.0005 with a mean absolute deviation of 0.000051, mean absolute percentage error of 0, and the sum of the absolute errors of 0.Please note that although there have been many attempts to predict Cannabis Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Cannabis Bioscience's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Cannabis Bioscience Pink Sheet Forecast Pattern
Cannabis Bioscience Forecasted Value
In the context of forecasting Cannabis Bioscience's Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Cannabis Bioscience's downside and upside margins for the forecasting period are 0.000005 and 17.40, respectively. We have considered Cannabis Bioscience's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Cannabis Bioscience pink sheet data series using in forecasting. Note that when a statistical model is used to represent Cannabis Bioscience pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 98.8652 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 1.0E-4 |
| MAPE | Mean absolute percentage error | 0.0939 |
| SAE | Sum of the absolute errors | 0.0031 |
Predictive Modules for Cannabis Bioscience
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cannabis Bioscience. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cannabis Bioscience Estimiated After-Hype Price Prediction Volatility
As far as predicting the price of Cannabis Bioscience at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Cannabis Bioscience or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Cannabis Bioscience, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Cannabis Bioscience Pink Sheet Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Cannabis Bioscience is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Cannabis Bioscience backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Cannabis Bioscience, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.75 | 17.40 | 0.00 | 0.07 | 0 Events / Month | 1 Events / Month | In 5 to 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
0.0005 | 0.0003 | 36.36 |
|
Cannabis Bioscience Hype Timeline
Cannabis Bioscience is currently traded for 0.0005. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.07. Cannabis is forecasted to decline in value after the next headline, with the price expected to drop to 3.18E-4. The average volatility of media hype impact on the company price is insignificant. The price decrease on the next news is expected to be -36.36%, whereas the daily expected return is currently at 1.75%. The volatility of related hype on Cannabis Bioscience is about 45789.47%, with the expected price after the next announcement by competition of 0.07. Given the investment horizon of 90 days the next forecasted press release will be in 5 to 10 days. Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.Cannabis Bioscience Related Hype Analysis
Having access to credible news sources related to Cannabis Bioscience's direct competition is more important than ever and may enhance your ability to predict Cannabis Bioscience's future price movements. Getting to know how Cannabis Bioscience's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Cannabis Bioscience may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| IONKF | Ionic Brands Corp | 0.38 | 4 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| AUSAF | Australis Capital | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| LOBEF | Lobe Sciences | 0.00 | 0 per month | 32.67 | 0.33 | 912.50 | (90.12) | 1,084 | |
| AYRWF | AYR Strategies Class | 0.00 | 0 per month | 18.23 | 0.11 | 47.83 | (25.00) | 275.00 | |
| DHBUF | Delivra Health Brands | 0.00 | 0 per month | 0.00 | (0.04) | 12.50 | (12.50) | 50.00 | |
| CVSI | CV Sciences | 0.00 | 0 per month | 9.46 | 0.08 | 25.00 | (22.22) | 153.57 | |
| HYEX | Grey Cloak Tech | 0.00 | 0 per month | 8.91 | 0.09 | 29.61 | (20.89) | 101.84 | |
| BUDZ | Weed Inc | 0.00 | 0 per month | 8.30 | 0.03 | 20.47 | (16.50) | 50.40 | |
| PCLOF | Pharmacielo | 0.00 | 0 per month | 13.54 | 0.14 | 43.48 | (23.33) | 288.60 | |
| RPNRF | Rapid Nutrition PLC | 0.00 | 0 per month | 0.00 | 0.12 | 0.00 | 0.00 | 99,900 |
Other Forecasting Options for Cannabis Bioscience
For every potential investor in Cannabis, whether a beginner or expert, Cannabis Bioscience's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cannabis Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cannabis. Basic forecasting techniques help filter out the noise by identifying Cannabis Bioscience's price trends.Cannabis Bioscience Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cannabis Bioscience pink sheet to make a market-neutral strategy. Peer analysis of Cannabis Bioscience could also be used in its relative valuation, which is a method of valuing Cannabis Bioscience by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cannabis Bioscience Market Strength Events
Market strength indicators help investors to evaluate how Cannabis Bioscience pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cannabis Bioscience shares will generate the highest return on investment. By undertsting and applying Cannabis Bioscience pink sheet market strength indicators, traders can identify Cannabis Bioscience International entry and exit signals to maximize returns.
| Accumulation Distribution | 39234.67 | |||
| Daily Balance Of Power | (2.00) | |||
| Rate Of Daily Change | 0.71 | |||
| Day Median Price | 6.0E-4 | |||
| Day Typical Price | 5.0E-4 | |||
| Price Action Indicator | (0.0001) | |||
| Period Momentum Indicator | (0.0002) |
Cannabis Bioscience Risk Indicators
The analysis of Cannabis Bioscience's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cannabis Bioscience's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cannabis pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 12.21 | |||
| Semi Deviation | 11.43 | |||
| Standard Deviation | 17.39 | |||
| Variance | 302.28 | |||
| Downside Variance | 380.42 | |||
| Semi Variance | 130.56 | |||
| Expected Short fall | (26.56) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Cannabis Bioscience
The number of cover stories for Cannabis Bioscience depends on current market conditions and Cannabis Bioscience's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Cannabis Bioscience is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Cannabis Bioscience's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios